Oxygen Consumption with High-Flow Nasal Oxygen versus Mechanical Ventilation- An International Multicenter Observational Study in COVID-19 Patients (PROXY-COVID)
- PMID: 36972693
- PMCID: PMC10160903
- DOI: 10.4269/ajtmh.22-0793
Oxygen Consumption with High-Flow Nasal Oxygen versus Mechanical Ventilation- An International Multicenter Observational Study in COVID-19 Patients (PROXY-COVID)
Abstract
The COVID-19 pandemic led to local oxygen shortages worldwide. To gain a better understanding of oxygen consumption with different respiratory supportive therapies, we conducted an international multicenter observational study to determine the precise amount of oxygen consumption with high-flow nasal oxygen (HFNO) and with mechanical ventilation. A retrospective observational study was conducted in three intensive care units (ICUs) in the Netherlands and Spain. Patients were classified as HFNO patients or ventilated patients, according to the mode of oxygen supplementation with which a patient started. The primary endpoint was actual oxygen consumption; secondary endpoints were hourly and total oxygen consumption during the first two full calendar days. Of 275 patients, 147 started with HFNO and 128 with mechanical ventilation. Actual oxygen use was 4.9-fold higher in patients who started with HFNO than in patients who started with ventilation (median 14.2 [8.4-18.4] versus 2.9 [1.8-4.1] L/minute; mean difference = 11.3 [95% CI 11.0-11.6] L/minute; P < 0.01). Hourly and total oxygen consumption were 4.8-fold (P < 0.01) and 4.8-fold (P < 0.01) higher. Actual oxygen consumption, hourly oxygen consumption, and total oxygen consumption are substantially higher in patients that start with HFNO compared with patients that start with mechanical ventilation. This information may help hospitals and ICUs predicting oxygen needs during high-demand periods and could guide decisions regarding the source of distribution of medical oxygen.
Figures




Similar articles
-
High flow nasal oxygen in frail COVID-19 patients hospitalized in intermediate care units and non-eligible to invasive mechanical ventilation.Respir Med Res. 2023 Nov;84:101026. doi: 10.1016/j.resmer.2023.101026. Epub 2023 May 19. Respir Med Res. 2023. PMID: 37717386 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study.Crit Care. 2020 Oct 6;24(1):597. doi: 10.1186/s13054-020-03314-6. Crit Care. 2020. PMID: 33023669 Free PMC article.
-
High-Flow Nasal Oxygen and Noninvasive Ventilation for COVID-19.Crit Care Clin. 2022 Jul;38(3):601-621. doi: 10.1016/j.ccc.2022.01.006. Epub 2022 Jan 10. Crit Care Clin. 2022. PMID: 35667746 Free PMC article. Review.
-
[The perioperative role of high-flow cannula oxygen (HFNO)].Rev Mal Respir. 2023 Jan;40(1):61-77. doi: 10.1016/j.rmr.2022.11.004. Epub 2022 Dec 7. Rev Mal Respir. 2023. PMID: 36496314 Review. French.
Cited by
-
A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death.Healthcare (Basel). 2023 Apr 3;11(7):1025. doi: 10.3390/healthcare11071025. Healthcare (Basel). 2023. PMID: 37046952 Free PMC article.
-
Management of adult sepsis in resource-limited settings: global expert consensus statements using a Delphi method.Intensive Care Med. 2025 Jan;51(1):21-38. doi: 10.1007/s00134-024-07735-7. Epub 2024 Dec 23. Intensive Care Med. 2025. PMID: 39714613 Free PMC article. Review.
-
Ringing a bell in healthcare: harnessing benefits, overcoming implementation challenges, and bridging knowledge gaps of Closed-Loop Oxygen Control systems (CLOCs).Einstein (Sao Paulo). 2024 Mar 25;22:eCE0910. doi: 10.31744/einstein_journal/2024CE0910. eCollection 2024. Einstein (Sao Paulo). 2024. PMID: 38536972 Free PMC article. No abstract available.
References
-
- Meara JG. et al., 2015. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 386: 569–624. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical